Show results for
Refine by
Respiratory Disease Services Available In Iran
7 services found
Manufactured by:PARI GmbH based in, UNITED KINGDOM
The inhalation of medications is currently the standard of care for chronic respiratory diseases. So that you and your patients can benefit from inhalation therapy that is efficient and perfectly hygienic in the long-term, we recommend that you pay special attention to several points with respect to the hygienic preparation of ...
by:ICON plc based inDublin, IRELAND
Focused on the unique needs of device and diagnostics manufacturers, ICON has broad experience in supporting trials of respiratory disease and infectious disease affecting respiratory function. The prevalence of respiratory diseases will continue to rise as our global population ages and the ...
Manufactured by:Vaxdyn, S. L. based inDos Hermanas (Sevilla), SPAIN
AMReady (2021-2024): “Development and manufacturing of vaccines for alleviation and preparedness fot anti-mirobial resistance global health crisis” is a project founded by the competitive program Líneas Estratégicas de Colaboración Público-Privada 2021 of the State Research Agency of the Spanish Ministry of Science and Innovation, in the Recovery and ...
Manufactured by:Atriva Therapeutics GmbH based inTübingen, GERMANY
The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two disease areas with urgent need for effective ...
by:Kadhema Scientific Consultancy and Services (KSCS) based inSafat, KUWAIT
Harvard School of Public Health in cooperation with Kadhema Scientific Consultancy and Services contracted by Public Authority for Assessment of Compensation for Damages resulting from the Iraqi Aggression (PAAC) carried out the health studies of the Environmental and Assessment (E&A) programme funded by the United Nations Compensation ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
COVID-19 is caused by infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may cause clusters of severe respiratory illness associated with the need for intensive care unit (ICU) admission and high mortality. Studies have shown that Acute Respiratory Distress Syndrome (ARDS) following viral pneumonia is one of the most common causes of death from ...
by:Teijin Limited based inTokyo, JAPAN
Focusing on the three key therapeutic areas: bone and joint, respiratory, and cardiovascular and metabolic diseases, the Teijin Group is promoting global business expansion led by the twin driving forces of pharmaceuticals and home ...